feed,title,long_url,short_url
SeekingAlpha,Hallucinogenic-drug maker Atai Life Sciences' stock pops 50%+ intraday after IPO,https://seekingalpha.com/news/3707738,
SeekingAlpha,Orphazyme plunges as hype-driven rally unravels after FDA decision,https://seekingalpha.com/news/3707737,
